When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NVO - Xeris Pharma's Gvoke: Strong Approval Chances But This Is A Highly Competitive Space
Novo Nordisk A/S
Xeris Pharmaceuticals Inc. (XERS) has a PDUFA on September 10, 2019, for a device-drug combo that delivers room-temperature, ready-to-use glucagon to hypoglycemia patients. Last year, around September, a month before its NDA was accepted by the FDA, the stock traded at its all-time high of around $28. Then it fell. It had a brief rally around October, when the NDA acceptance news came out; then it started falling. The free fall continued all the way till February, when the company announced a secondary. Then it fell some more. Finally, the stock found bottom